Tiszlavicz Z, Nmeth B, Flp F, Vcsei L, Tpai K, Ocsovszky I, et al
L., Heymann, C
CJC-1295 initiates a broad GH release, and Ipamorelin (no DAC) enhances and extends this effect by acting on separate signaling pathways
It is currently classified as a research peptide and has not been evaluated by the FDA for safety or efficacy in humans
It is not approved for general weight loss, bodybuilding, or anti-aging, and the visceral-fat benefit reverses when the drug is stopped
chinensis were examined, and the root of the plant was also defined as a perspective to direction further studies, which include extraction and determination of the content of the main substances (Jung et al., 2016)